Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus

Peptides

Volumn 25, Issue 6, 2004, Pages 901-908

  Wu, Guang ^a   Yan, Shaomin ^a  

^a DreamSciTech Consulting   (China)

Author keywords

Amino acid pairs; Coronavirus; Drug targets; SARS

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; ENVELOPE PROTEIN; MEMBRANE PROTEIN; NUCLEOCAPSID PROTEIN; RNA DIRECTED RNA POLYMERASE; STRUCTURAL PROTEIN; VIRUS ENZYME; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; DRUG PROTEIN BINDING; DRUG TARGETING; GENE MUTATION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS NUCLEOCAPSID;

ANTIVIRAL AGENTS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; HUMANS; PROBABILITY; SARS VIRUS; SEQUENCE ANALYSIS, PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL STRUCTURAL PROTEINS;

CORONAVIRUS;

EID: 2942528833     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.03.002     Document Type: Article

References (35)

1. Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 300:2003;1763-1767
2. Bairoch A., Apweiler R. The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 2000. Nucl. Acids Res. 28:2000;45-48
3. Bermejo Martin J.F., Jimenez J.L., Munoz-Fernandez A. Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Med. Sci. Monit. 9:2003;SR29-SR34
4. Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77:2003;8801-8811
5. Chen L.L., Ou H.Y., Zhang R., Zhang C.T. ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. Biochem. Biophys. Res. Commun. 307:2003;382-388
6. Chou K.C., Wei D.Q., Zhong W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Commun. 308:2003;148-151
7. Davidson A., Siddell S. Potential for antiviral treatment of severe acute respiratory syndrome. Curr. Opin. Infect. Dis. 16:2003;565-571
8. Feller W. An introduction to probability theory and its applications, 3rd ed., vol. I. New York: Wiley; 1968.
9. Kim M.S., Hashemi S.B., Spencer P.S., Sabri M.I. Amino acid and protein targets of 1, 2-diacetylbenzene, a potent aromatic gamma-diketone that induces proximal neurofilamentous axonopathy. Toxicol. Appl. Pharmacol. 183:2002;55-65
10. Leparc-Goffart I., Hingley S.T., Chua M.M., Phillips J., Lavi E., Weiss S.R. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J. Virol. 72:1998;9628-9636
11. Liu S., Pei J., Chen H., Zhu X., Liu Z., Ma W., et al. Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site. Beijing Da Xue Xue Bao. 35(Suppl):2003;62-65
12. Moffatt J., Kennedy D.O., Kojima A., Hasuma T., Yano Y., Otani S., et al. Involvement of protein tyrosine phosphorylation and reduction of cellular sulfhydryl groups in cell death induced by 1′-acetoxychavicol acetate in Ehrlich ascites tumor cells. Chem. Biol. Interact. 139:2002;215-230
13. PROSITE: a dictionary of protein sites and patterns user manual, http://www.expasy.ch/prosite/.
14. Sanchez C.M., Izeta A., Sanchez-Morgado J.M., Alonso S., Sola I., Balasch M., et al. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J. Virol. 73:1999;7607-7618
15. Shen X., Xue J.H., Yu C.Y., Luo H.B., Qin L., Yu X.J., et al. Small envelope protein E of SARS: cloning, expression, purification, CD determination, and bioinformatics analysis. Acta Pharmacol. Sin. 24:2003;505-511
16. Szabo K., Bakos E., Welker E., Muller M., Goodfellow H.R., Higgins C.F., et al. Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity. J. Biol. Chem. 272:1997;23165-23171
17. Tsui S.K., Chim S.S., Lo Y.M. Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. N. Engl. J. Med. 349:2003;187-188
18. van der Lubbe JCA. Information theory. Cambridge: Cambridge University Press; 1997.
19. Vaughan M.D., Sampson P.B., Honek J.F. Methionine in and out of proteins: targets for drug design. Curr. Med. Chem. 9:2002;385-409
20. Williams R.K., Yeager C.L., Holmes K.V. Potential for receptor-based antiviral drugs against SARS. Lancet. 362:2003;77
21. Wu G. Frequency and Markov chain analysis of amino-acid sequence of human tumor necrosis factor. Cancer Lett. 153:2000;145-150
22. Wu G. Frequency and Markov chain analysis of amino-acid sequence of human glutathione reductase. Biochem. Biophys. Res. Commun. 268:2000;823-826
23. Wu G. Frequency and Markov chain analysis of amino-acid sequences of mouse p53. Human Exp. Toxicol. 19:2000;535-539
24. Wu G., Yan S.M. Prediction of two- and three-amino acid sequence of human acute myeloid leukemia 1 protein from its amino acid composition. Comp. Haematol. Int. 10:2000;85-89
25. Wu G., Yan S.M. Prediction of two- and three-amino-acid sequences of Citrobacter Freundii β-lactamase from its amino acid composition. J. Mol. Microbiol. Biotechnol. 2:2000;277-281
26. Wu G., Yan S.M. Prediction of presence and absence of two- and three-amino-acid sequence of human monoamine oxidase B from its amino acid composition according to the random mechanism. Biomol. Eng. 18:2001;23-27
27. Wu G., Yan S.M. Frequency and Markov chain analysis of amino-acid sequences of human connective tissue growth factor. J. Mol. Model. 5:2001;120-124
28. Wu G., Yan S.M. Mathematical model of time needed for the immune system to detect and kill cancer cells in blood. Comput. Clin. Pathol. 11:2002;178-183
29. Wu G., Yan S.M. Random analysis of presence and absence of two- and three-amino-acid sequences and distributions of amino acids, two- and three-amino-acid sequences in bovine p53 protein. Mol. Biol. Today. 3:2002;31-37
30. Wu G., Yan S.M. Randomness in the primary structure of protein: methods and implications. Mol. Biol. Today. 3:2002;55-56
31. Wu G., Yan S.M. Estimation of amino acid pairs sensitive to variants in human phenylalanine hydroxylase protein by means of a random approach. Peptides. 23:2002;2085-2090
32. Wu G., Yan S. Analysis of amino acid pairs sensitive to variants in human collagen a5(IV) chain precursor by means of a random approach. Peptides. 24:2003;347-352
33. Wu G., Yan S. Determination of amino acid pairs sensitive to variants in human β-glucocerebrosidase by means of a random approach. Protein Eng. 16:2003;195-199
34. Wu G., Yan S. Determination of amino acid pairs in human p53 protein sensitive to mutations/variants by means of a random approach. J. Mol. Model. 9:2003;337-341
35. Wu G., Yan S. Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus. Peptides. 24:2003;1837-1845